Middle East Respiratory Syndrome Virus Pathogenesis

Seminars in Respiratory and Critical Care Medicine

Volumn 37, Issue 4, 2016, Pages 572-577

  Singh, Sunit K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

coronavirus; MERS CoV; SARS CoV

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; VIRUS RNA;

ARTICLE; CORONAVIRUS INFECTION; DIABETES MELLITUS; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FRANCE; GERMANY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERKALEMIA; IMMUNOPATHOGENESIS; INNATE IMMUNITY; ITALY; KIDNEY FAILURE; MIDDLE EAST; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY RATE; MULTIPLE ORGAN FAILURE; NONHUMAN; OPEN READING FRAME; PERICARDITIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN MICROARRAY; REAL TIME POLYMERASE CHAIN REACTION; SPAIN; TUNISIA; UNITED KINGDOM; VIRAL CLEARANCE; ANIMAL; CAMEL; COMPLICATION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TRANSMISSION; VIROLOGY;

ANIMALS; CAMELUS; CORONAVIRUS INFECTIONS; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 84982711427     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0036-1584796     Document Type: Article

References (75)

1. Woo P. C., Lau S. K., Chu C. M., et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol: 2005; 79 2 884 895
2. Durai P., Batool M., Shah M., Choi S. Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control. Exp Mol Med: 2015; 47 e181
3. Weiss S. R., Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev: 2005; 69 4 635 664
4. Fouchier R. A., Hartwig N. G., Bestebroer T. M., et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A: 2004; 101 16 6212 6216
5. van den Brand J. M., Smits S. L., Haagmans B. L. Pathogenesis of Middle East respiratory syndrome coronavirus. J Pathol: 2015; 235 2 175 184
6. Gaunt E. R., Hardie A., Claas E. C., Simmonds P., Templeton K. E. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol: 2010; 48 8 2940 2947
7. Álvarez E., Donado-Campos J., Morilla F. New coronavirus outbreak. Lessons learned from the severe acute respiratory syndrome epidemic. Epidemiol Infect: 2015; 143 13 2882 2893
8. Sharif-Yakan A., Kanj S. S. Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives. PLoS Pathog: 2014; 10 12 e1004457
9. Woo P. C., Lau S. K., Li K. S., Tsang A. K., Yuen K. Y. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg Microbes Infect: 2012; 1 11 e35
10. de Groot R. J., Baker S. C., Baric R. S., et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol: 2013; 87 14 7790 7792
11. Woo P. C., Lau S. K., Li K. S., et al. Molecular diversity of coronaviruses in bats. Virology: 2006; 351 1 180 187
12. Reusken C. B., Lina P. H., Pielaat A., et al. Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe. Vector Borne Zoonotic Dis: 2010; 10 8 785 791
13. van Boheemen S., de Graaf M., Lauber C., et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio: 2012; 3 6 473 512
14. Ithete N. L., Stoffberg S., Corman V. M., et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis: 2013; 19 10 1697 1699
15. Haagmans B. L., Al Dhahiry S. H., Reusken C. B., et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis: 2014; 14 2 140 145
16. Banik G. R., Khandaker G., Rashid H. Middle East respiratory syndrome coronavirus MERS-CoV: current knowledge gaps. Paediatr Respir Rev: 2015; 16 3 197 202
17. Reusken C. B., Haagmans B. L., Müller M. A., et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis: 2013; 13 10 859 866
18. Perera R. A., Wang P., Gomaa M. R., et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill: 2013; 18 36 20574
19. van Doremalen N., Bushmaker T., Karesh W. B., Munster V. J. Stability of Middle East respiratory syndrome coronavirus in milk. Emerg Infect Dis: 2014; 20 7 1263 1264
20. Alagaili A. N., Briese T., Karesh W. B., Daszak P., Lipkin W. I. Reply to Concerns about misinterpretation of recent scientific data implicating dromedary camels in epidemiology of Middle East respiratory syndrome (MERS) MBio: 2014; 5 4 e01482 e14
21. Azhar E. I., El-Kafrawy S. A., Farraj S. A., et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med: 2014; 370 26 2499 2505
22. Vijgen L., Keyaerts E., Lemey P., et al. Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43. J Virol: 2006; 80 14 7270 7274
23. de Sousa R., Reusken C., Koopmans M. MERS coronavirus: data gaps for laboratory preparedness. J Clin Virol: 2014; 59 1 4 11
24. Assiri A., McGeer A., Perl T. M., et al. KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med: 2013; 369 5 407 416
25. Raj V. S., Osterhaus A. D., Fouchier R. A., Haagmans B. L. MERS: emergence of a novel human coronavirus. Curr Opin Virol: 2014; 5 58 62
26. Arabi Y. M., Arifi A. A., Balkhy H. H., et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med: 2014; 160 6 389 397
27. Assiri A., Al-Tawfiq J. A., Al-Rabeeah A. A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis: 2013; 13 9 752 761
28. Zhang N., Jiang S., Du L. Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Rev Vaccines: 2014; 13 6 761 774
29. Tomar S., Johnston M. L., St John S. E., et al. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS. J Biol Chem: 2015; 290 32 19403 19422
30. Bailey-Elkin B. A., Knaap R. C., Johnson G. G., et al. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem: 2014; 289 50 34667 34682
31. Perlman S., Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol: 2009; 7 6 439 450
32. Zumla A., Hui D. S., Perlman S. Middle East respiratory syndrome. Lancet: 2015; 386 9997 995 1007
33. Smith E. C., Blanc H., Surdel M. C., Vignuzzi M., Denison M. R. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog: 2013; 9 8 e1003565
34. Kindler E., Jónsdóttir H. R., Muth D., et al. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio: 2013; 4 1 e00611 e00612
35. Zielecki F., Weber M., Eickmann M., et al. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol: 2013; 87 9 5300 5304
36. Raj V. S., Mou H., Smits S. L., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature: 2013; 495 7440 251 254
37. Li W., Moore M. J., Vasilieva N., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature: 2003; 426 6965 450 454
38. Perlman S. The Middle East respiratory syndrome--how worried should we be? MBio: 2013; 4 4 531 613
39. Hocke A. C., Becher A., Knepper J., et al. Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs. Am J Respir Crit Care Med: 2013; 188 7 882 886
40. de Wilde A. H., Raj V. S., Oudshoorn D., et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment. J Gen Virol: 2013; 94 Pt 8 1749 1760
41. Delmas B., Gelfi J., L'Haridon R., et al. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature: 1992; 357 6377 417 420
42. Raj V. S., Smits S. L., Provacia L. B., et al. Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus. J Virol: 2014; 88 3 1834 1838
43. Jiang S., Lu L., Du L., Debnath A. K. A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC. J Infect: 2013; 66 5 464 466
44. Imai Y., Kuba K., Ohto-Nakanishi T., Penninger J. M. Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J: 2010; 74 3 405 410
45. Herlihy S. E., Pilling D., Maharjan A. S., Gomer R. H. Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellent. J Immunol: 2013; 190 12 6468 6477
46. Gierer S., Bertram S., Kaup F., et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol: 2013; 87 10 5502 5511
47. Lambeir A. M., Durinx C., Scharpé S., De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci: 2003; 40 3 209 294
48. Cowling B. J., Park M., Fang V. J., Wu P., Leung G. M., Wu J. T. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill: 2015; 20 25 7 13
49. Chan R. W., Chan M. C., Agnihothram S., et al. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol: 2013; 87 12 6604 6614
50. Zhou J., Chu H., Li C., et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis: 2014; 209 9 1331 1342
51. Lau S. K., Lau C. C., Chan K. H., et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol: 2013; 94 Pt 12 2679 2690
52. Cameron M. J., Ran L., Xu L., et al. Canadian SARS Research Network. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol: 2007; 81 16 8692 8706
53. Al-Tawfiq J. A., Hinedi K., Ghandour J., et al. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis: 2014; 59 2 160 165
54. Memish Z. A., Al-Tawfiq J. A., Assiri A., et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J: 2014; 33 9 904 906
55. Guery B., Poissy J., el Mansouf L., et al. MERS-CoV Study Group. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet: 2013; 381 9885 2265 2272
56. Drosten C., Seilmaier M., Corman V. M., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis: 2013; 13 9 745 751
57. Memish Z. A., Assiri A., Almasri M., et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis: 2014; 210 7 1067 1072
58. Al-Abdallat M. M., Payne D. C., Alqasrawi S., et al. Jordan MERS-CoV Investigation Team. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis: 2014; 59 9 1225 1233
59. Ajlan A. M., Ahyad R. A., Jamjoom L. G., Alharthy A., Madani T. A. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol: 2014; 203 4 782 787
60. Nicholls J. M., Poon L. L., Lee K. C., et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet: 2003; 361 9371 1773 1778
61. Tse G. M., To K. F., Chan P. K., et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol: 2004; 57 3 260 265
62. Josset L., Menachery V. D., Gralinski L. E., et al. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. MBio: 2013; 4 3 e00165 e13
63. Faure E., Poissy J., Goffard A., et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS ONE: 2014; 9 2 e88716
64. Meyer B., Drosten C., Müller M. A. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res: 2014; 194 175 183
65. Spanakis N., Tsiodras S., Haagmans B. L., et al. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. Int J Antimicrob Agents: 2014; 44 6 528 532
66. Gossner C., Danielson N., Gervelmeyer A., et al. Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection. Zoonoses Public Health: 2016; 63 1 1 9
67. Shirato K., Yano T., Senba S., et al. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J: 2014; 11 139
68. Du L., Zhao G., Kou Z., et al. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol: 2013; 87 17 9939 9942
69. Raj V. S., Lamers M. M., Smits S. L., et al. Identification of protein receptors for coronaviruses by mass spectrometry. Methods Mol Biol: 2015; 1282 165 182
70. Memish Z. A., Al-Tawfiq J. A., Makhdoom H. Q., et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis: 2014; 210 10 1590 1594
71. Chong Y. P., Song J. Y., Seo Y. B., Choi J. P., Shin H. S.; Rapid Response Team. Antiviral treatment guidelines for Middle East respiratory syndrome. Infect Chemother: 2015; 47 3 212 222
72. Chan J. F., Yao Y., Yeung M. L., et al. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis: 2015; 212 12 1904 1913
73. Gara N., Ghany M. G. What the infectious disease physician needs to know about pegylated interferon and ribavirin. Clin Infect Dis: 2013; 56 11 1629 1636
74. Mair-Jenkins J., Saavedra-Campos M., Baillie J. K., et al. Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis: 2015; 211 1 80 90
75. Hui D. S., Memish Z. A., Zumla A. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med: 2014; 20 3 233 241